Press Releases

Year None20222021202020192018

January 11, 2022

Black Diamond Therapeutics Announces FDA Allowance of IND Application for BDTX-1535, A MasterKey Inhibitor of EGFR for the Treatment of Gliobastoma and Non-Small Cell Lung Cancer

January 10, 2022

Black Diamond Therapeutics Announces Strategic Priorities and Expected Milestones for 2022

January 05, 2022

Black Diamond Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

Displaying 11 - 13 of 13